Elligo Health Research Stock

Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.

Sign up today and learn more about Elligo Health Research Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Elligo Health Research Stock

Elligo Health Research is a healthcare company that revolutionizes the clinical research industry with a novel approach to common trial challenges including patient participation and enrollment, and physician participation. They provide physicians and their patients the opportunity to participate in clinical trials using advanced health care informatics. Improved access to physicians and patients means sponsors reach trial enrollment goals faster, and new products are accelerated to market, benefiting patients everywhere. It brings clinical research to physician practices, accelerating the development of pharmaceutical, biotechnology, and medical device products and therapies. Elligo Health Research was founded in 2016 and is headquartered in Austin, Texas.

Funding History

March 2018$16.0M
May 2019$20.0M
September 2021$135M



John Potthoff


Chad Moore


Jacylyn Bodmer


Karen Flaherty


Eli Alford

Chief Legal Officer

Amy Staedtler

Board Observer

Nathan Cohen

Chief Data Officer

Michael Ibara

Board Director

Steven Skolsky

Board Observer

Gary Abrahams

Executive Vice President, Research Operations

Juliet Moritz

Director, Healthcare Partnerships

Doug Olsen


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: